Skip to content

Crosstalk between α-synuclein accumulation, NLRP3 inflammasome activation, oxidative stress, and apoptosis in a rotenone-induced Parkinson rat model.

Aug 2026 · Biochemical and Biophysical Research Communications - BBRC · Vol 834, pp. 154459 · 0 citations · 52 references
Medicine

TL;DR

A synergistic pathogenic cascade where α-synuclein accumulation contributes to neuroinflammation and oxidative stress, suppressing antioxidant defenses and activating apoptotic pathways is suggested, ultimately leading to dopaminergic neuron death and severe motor dysfunction.

Abstract

Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons. This study aimed to elucidate the dynamic interplay between these pathological pathways in a rotenone-induced rat model of PD. Adult male Wistar rats were chronically treated with rotenone. Behavioral assessments included Rotarod, Open Field, Rotating Pole, and Cylinder tests. On days 7, 14, and 21, gene expression levels of key markers including α-synuclein, NLRP3 inflammasome components (NLRP3, ASC), inflammatory cytokines (IL-1β, TNF-α, IL-6), upstream signaling molecules (TLR4, NF-κB), antioxidant defense factors (Nrf2, HO-1), apoptotic regulators (Bax, Bcl-2, Caspase-3), and tyrosine hydroxylase (TH) were quantified via qPCR. Crucially, protein abundance for all major markers was validated using ELISA, alongside biochemical assessment of oxidative stress markers (MDA and SOD). Rotenone treatment caused a progressive decline in motor performance across all behavioral assays (p < 0.001), including reduced rotarod latency, decreased open field distance, increased pole test latency, and heightened cylinder asymmetry. The PD group exhibited significant time-dependent increases in α-synuclein, TLR4, NF-κB, NLRP3, ASC, IL-1β, IL-6, TNF-α, Bax, Caspase-3, and MDA levels. Conversely, expression levels of Nrf2, HO-1, Bcl-2, and SOD activity showed marked decreases (p < 0.01). Finally, TH expression decreased progressively, reaching roughly 50% of control levels at day 21. Correlation analysis confirmed strong links between α-synuclein accumulation, inflammation, oxidative damage, and neuronal loss. These findings suggest a synergistic pathogenic cascade where α-synuclein accumulation contributes to neuroinflammation and oxidative stress, suppressing antioxidant defenses and activating apoptotic pathways, ultimately leading to dopaminergic neuron death and severe motor dysfunction.

View source

Similar papers

Open access Sep 2026

Gomisin N ameliorates autophagy-neuroinflammation imbalance in Parkinson's disease models via modulating the ATG16L1/NLRP3 axis.

GN is a brain-penetrant preclinical candidate that links ATG16L1-dependent autophagy with α-synuclein clearance and NLRP3 inflammasome suppression in PD models and completely abrogated the neuroprotective and anti-inflammatory effects of GN both in vitro and in vivo.

Cheng-Fu Su, Zhi-Qiang Deng, Ka-Yee Ying et al. · 0 citations
Open access Sep 2026

Targeting TLR4/NF-κB/NLRP3 signaling with 6-hydroxyflavanone mitigates amyloid-β-induced Alzheimer's disease in mice.

6-OH-F ameliorates Aβ-induced cognitive impairment by attenuating oxidative stress, neuroinflammation, and pyroptotic signaling, potentially through modulation of the TLR4/NF-κB/NLRP3 pathway, highlighting its therapeutic potential in Alzheimer's disease.

Debarati Rakshit, Mohit Nema, Awanish Mishra · 0 citations
Aug 2026

Astragalin confers coordinated neuroprotection in Parkinson's disease models through modulation of neurotrophic, anti-inflammatory, and synuclein-related pathways.

The natural flavonoid Astragalin concurrently addresses three core pathological processes in PD, namely dopaminergic neuron degeneration, α-synucleinopathy, and neuroinflammation, through coordinated modulation of interconnected molecular pathways.

Jun Wang, Jie-Yu He, Qin Huang et al. · 0 citations
Aug 2026

Honokiol Targets Cyclophilin D and Blocks Mitochondrial DNA Release to Inhibit Microglial NLRP3 Inflammasome Activation and Alleviate Neurodegeneration in Parkinson's Disease Models.

Parkinson's disease (PD) is linked to neuroinflammation, and the current focus of treating PD is to alleviate its pathological symptoms rather than neuroprotection. Honokiol (HNK), an active component of Magnolia officinalis, has been reported to be neuroprotective in PD models, but its mechanism remains unclear. In th...

Qinglin Gan, Yingtong Xian, Ting Zhou et al. · 0 citations
Open access Sep 2026

Trans-Vitisin B Targets Neuroinflammation, Oxidative Stress, and Tau Pathology to Improve Behavioral Outcomes in a Mouse Model of Parkinson’s Disease

Unlike L-DOPA’s direct dopaminergic stimulation, tVB’s neuroprotective efficacy is mediated through multilevel regulation of key PD pathogenetic pathways, including neuroinflammation, oxidative stress, and impaired proteostasis.

Evgeniy A. Pislyagin, I. Manzhulo, Irina Agafonova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.